| Literature DB >> 36011269 |
Yong Liu1, Shuangmin Liang2, Kun Wang1, Xiannian Zi1, Ru Zhang1, Guangzheng Wang1, Jiajia Kang1, Zijian Li1, Tengfei Dou1, Changrong Ge1.
Abstract
Poultry is an important dietary source of animal protein, accounting for approximately 30% of global meat consumption. Because of its low price, low fat and cholesterol content, and no religious restrictions, chicken is considered a widely available healthy meat. Chahua chicken No. 2 is a synthetic breed of Chahua chicken derived from five generations of specialized strain breeding. In this study, Chahua chicken No. 2 (CH) and Yao chicken (Y) were used as the research objects to compare the differences in physicochemical and nutritional indicators of meat quality between the two chicken breeds, and metabolomics was used to analyze the differences in metabolites and lipid metabolism pathways and to explore the expression of genes involved in adipogenesis. The physical index and nutritional value of CH are better than that of Y, and the chemical index of Y is better than that of CH. However, the chemical index results of CH are also within the normal theoretical value range. Comprehensive comparison shows that the meat quality of CH is relatively good. Metabolomics analysis showed that CH and Y had 85 different metabolites, and the differential metabolites were mainly classified into eight categories. KEGG pathway enrichment analysis revealed 13 different metabolic pathways. The screened PPARG, FABP3, ACSL5, FASN, UCP3 and SC5D were negatively correlated with muscle fat deposition, while PPARα, ACACA and ACOX1 were positively correlated with muscle fat deposition. The meat quality of CH was better than Y. The metabolites and metabolic pathways obtained by metabonomics analysis mainly involved the metabolism of amino acids and fatty acids, which were consistent with the differences in meat quality between the two breeds and the contents of precursors affecting flavor. The screened genes were associated with fatty deposition in poultry.Entities:
Keywords: chicken; fat deposition; meat quality characteristics; metabonomics
Mesh:
Substances:
Year: 2022 PMID: 36011269 PMCID: PMC9407069 DOI: 10.3390/genes13081358
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.141
Figure 1Comparison of body weight and meat quality physical indexes between Y and CH. (A) Comparison of body weight of two chicken breeds. (B) Comparison of pH values between two males. (C) Comparison of pH values between two females. (D) Comparison of meat color between two males. (E) Comparison of meat color between two females. (F) Comparison of shear force between two males. (G) Comparison of shear force between two females. (H) Comparison of dehydration rate between two males. (I) Comparison of dehydration rate between two females. ** indicates extremely significant differences (p < 0.01); * indicates significant difference (p < 0.05).
Chemical composition of muscle of two chicken breeds.
| Items | ♂/♀ | Water (%) | CF (%) | CP (%) | Ash (%) | |
|---|---|---|---|---|---|---|
| Breast muscle | ♂ | Y | 72.65 ± 0.16 | 1.17 ± 0.02 * | 25.00 ± 0.18 | 1.53 ± 0.05 |
| CH | 72.20 ± 0.24 | 0.83 ± 0.06 | 26.67 ± 0.23 ** | 1.21 ± 0.07 | ||
| ♀ | Y | 72.53 ± 0.19 | 1.39 ± 0.09 * | 24.27 ± 0.37 | 1.89 ± 0.02 * | |
| CH | 71.43 ± 0.25 | 1.00 ± 0.03 | 26.68 ± 0.18 ** | 1.33 ± 0.08 | ||
| Leg muscle | ♂ | Y | 73.60 ± 0.13 | 1.47 ± 0.06 ** | 23.92 ± 0.32 | 1.77 ± 0.07 |
| CH | 72.86 ± 0.23 | 1.01 ± 0.13 | 25.60 ± 0.21 ** | 1.20 ± 0.06 | ||
| ♀ | Y | 72.94 ± 0.17 | 1.65 ± 0.09 ** | 23.99 ± 0.06 | 1.67 ± 0.06 * | |
| CH | 71.97 ± 0.60 | 1.21 ± 0.07 | 25.88 ± 0.11 ** | 1.08 ± 0.09 |
Note: Comparison of water, CF, CP and ash contents in the same part of CH and Y; ** indicates extremely significant differences (p < 0.01); * indicates significant difference (p < 0.05).
Amino acid content in muscles of males.
| Items | Breast Muscle | Leg Muscle | ||
|---|---|---|---|---|
| Y | CH | Y | CH | |
| Asp | 6.20 ± 0.70 | 8.08 ± 1.57 ** | 6.90 ± 1.31 | 8.10 ± 1.59 ** |
| Thr | 3.47 ± 0.21 | 4.03 ± 0.75 * | 3.03 ± 0.52 | 3.10 ± 0.68 |
| Ser | 1.37 ± 0.03 | 2.04 ± 0.60 * | 1.70 ± 0.38 | 2.03 ± 0.43 * |
| Glu | 8.42 ± 0.36 | 14.07 ± 2.45 ** | 9.07 ± 2.31 | 14.11 ± 2.70 ** |
| Gly | 5.27 ± 0.74 | 4.11 ± 0.78 | 5.80 ± 0.66 | 4.74 ± 1.08 |
| Ala | 4.32 ± 0.58 | 5.03 ± 0.97 * | 3.96 ± 0.79 | 5.21 ± 1.04 * |
| Cys | 0.36 ± 0.21 | 0.50 ± 0.13 * | 0.32 ± 0.15 | 0.44 ± 0.16 * |
| Val | 4.03 ± 0.52 | 4.12 ± 0.91 | 3.77 ± 0.78 | 4.21 ± 0.89 |
| Met | 0.37 ± 0.04 | 1.00 ± 0.28 ** | 0.37 ± 0.09 | 0.62 ± 0.26 ** |
| Ile | 3.92 ± 1.35 | 5.07 ± 0.87 * | 4.40 ± 0.81 | 5.02 ± 0.92 * |
| Leu | 7.27 ± 0.04 | 8.91 ± 1.30 * | 6.56 ± 1.18 | 7.34 ± 1.35 * |
| Tyr | 1.41 ± 0.45 | 2.22 ± 1.00 * | 1.12 ± 0.42 | 1.12 ± 0.43 |
| Phe | 3.36 ± 0.22 | 3.37 ± 0.59 | 3.19 ± 0.41 | 4.06 ± 0.66 * |
| His | 3.92 ± 2.25 | 4.13 ± 1.14 | 3.93 ± 0.73 | 4.24 ± 0.73 |
| Lys | 5.37 ± 0.45 | 6.29 ± 1.03 | 5.17 ± 1.27 | 5.96 ± 1.46 |
| Arg | 4.83 ± 0.48 | 6.19 ± 1.12 ** | 5.64 ± 0.91 | 6.60 ± 1.14 * |
| Pro | 3.74 ± 0.32 | 3.16 ± 0.52 | 3.99 ± 0.43 | 3.12 ± 0.71 |
| UAA | 19.31 ± 0.99 | 27.68 ± 1.40 ** | 20.29 ± 0.57 | 27.76 ± 1.10 ** |
| EAA | 28.39 ± 0.79 | 31.09 ± 0.53 * | 26.89 ± 0.91 | 30.32 ± 1.20 * |
| NEAA | 15.71 ± 0.21 | 15.66 ± 0.45 | 16.68 ± 0.21 | 15.25 ± 0.40 |
| TAA | 66.84 ± 1.98 | 79.62 ± 2.23 ** | 68.00 ± 2.03 | 77.93 ± 2.59 ** |
Note: Comparison of amino acid content in the same part of CH and Y males; ** indicates very significant difference (p < 0.01), * indicates significant difference (p < 0.05). UAA, umami amino acid; EAA, essential amino acid; NEAA, nonessential amino acid; TAA, total amino acid.
Amino acid content in muscles of females.
| Items | Breast Muscle | Leg Muscle | ||
|---|---|---|---|---|
| Y | CH | Y | CH | |
| Asp | 5.78 ± 0.71 | 8.30 ± 0.53 ** | 6.19 ± 2.17 | 7.96 ± 1.43 * |
| Thr | 3.17 ± 0.32 | 3.19 ± 0.35 | 3.10 ± 0.90 | 3.10 ± 0.65 |
| Ser | 1.24 ± 0.28 | 1.77 ± 0.33 | 1.65 ± 0.48 | 1.81 ± 0.47 |
| Glu | 10.19 ± 1.24 | 13.06 ± 0.90 ** | 9.75 ± 3.18 | 13.49 ± 2.43 ** |
| Gly | 4.16 ± 0.50 | 4.06 ± 0.18 | 4.81 ± 1.00 | 4.77 ± 1.14 |
| Ala | 4.02 ± 0.52 | 5.15 ± 0.30 * | 4.12 ± 1.33 | 5.06 ± 0.95 * |
| Cys | 0.31 ± 0.16 | 0.37 ± 0.07 | 0.26 ± 0.14 | 0.38 ± 0.06 |
| Val | 4.22 ± 0.46 | 4.30 ± 0.37 | 3.66 ± 1.31 | 4.48 ± 0.75 * |
| Met | 0.39 ± 0.15 | 0.46 ± 0.10 * | 0.30 ± 0.10 | 0.45 ± 0.19 ** |
| Ile | 4.59 ± 0.46 | 4.78 ± 0.37 | 4.36 ± 1.33 | 4.46 ± 0.77 |
| Leu | 6.72 ± 0.63 | 6.85 ± 0.51 | 6.69 ± 1.96 | 6.73 ± 1.15 |
| Tyr | 1.06 ± 0.38 | 1.55 ± 0.29 * | 1.00 ± 0.45 | 1.40 ± 0.29 * |
| Phe | 3.26 ± 0.30 | 3.29 ± 0.23 | 3.14 ± 0.75 | 3.71 ± 1.00 |
| His | 3.52 ± 0.30 | 3.61 ± 0.50 | 3.55 ± 2.35 | 3.92 ± 0.61 |
| Lys | 5.04 ± 0.67 | 6.08 ± 0.54 * | 4.94 ± 1.86 | 5.98 ± 1.27 * |
| Arg | 5.37 ± 0.59 | 5.79 ± 0.35 | 5.72 ± 1.45 | 5.79 ± 1.09 |
| Pro | 2.86 ± 0.37 | 2.85 ± 0.12 | 3.35 ± 0.65 | 3.30 ± 0.69 |
| UAA | 20.30 ± 0.99 | 26.88 ± 1.02 ** | 20.32 ± 0.11 | 26.88 ± 1.34 ** |
| EAA | 28.09 ± 0.96 | 28.95 ± 1.00 | 27.61 ± 0.69 | 28.89 ± 0.77 |
| NEAA | 13.03 ± 0.21 | 13.83 ± 0.46 | 13.96 ± 0.40 | 15.19 ± 0.27 |
| TAA | 64.89 ± 1.97 | 74.45 ± 2.11 ** | 65.51 ± 1.37 | 75.75 ± 2.00 ** |
Note: Comparison of amino acid content in the same part of CH and Y females; ** indicates very significant difference (p < 0.01), * indicates significant difference (p < 0.05). UAA, umami amino acid; EAA, essential amino acid; NEAA, nonessential amino acid; TAA, total amino acid.
Fatty acid content in muscles of males.
| Items | Breast Muscle | Leg Muscle | ||
|---|---|---|---|---|
| Y | CH | Y | CH | |
| C6:0 | 1.114 ± 0.134 * | 1.006 ± 0.201 | 1.086 ± 0.163 | 1.082 ± 0.173 |
| C8:0 | 1.040 ± 0.114 | 0.901 ± 0.135 | 0.996 ± 0.159 ** | 0.643 ± 0.084 |
| C10:0 | 0.658 ± 0.092 * | 0.591 ± 0.077 | 0.867 ± 0.113 ** | 0.645 ± 0.071 |
| C11:0 | ND | ND | ND | ND |
| C12:0 | 1.044 ± 0.146 | 1.140 ± 0.016 | 1.528 ± 0.214 | 1.564 ± 0.219 |
| C13:0 | 2.983 ± 0.298 ** | 2.108 ± 0.422 | 3.231 ± 0.485 * | 2.700 ± 0.459 |
| C14:0 | 14.105 ± 1.834 | 16.016 ± 1.202 * | 18.524 ± 2.964 | 19.810 ± 3.010 * |
| C14:1T | 8.703 ± 0.957 | 7.748 ± 1.007 | 8.778 ± 1.141 ** | 5.887 ± 0.765 |
| C14:1 | 4.908 ± 0.870 | 7.927 ± 0.246 ** | 15.771 ± 2.208 | 18.749 ± 2.062 * |
| C15:0 | 3.631 ± 0.436 * | 3.169 ± 0.634 | 4.325 ± 0.649 | 4.118 ± 0.576 |
| C15:1T | 3.351 ± 0.369 | 3.591 ± 0.646 * | 2.135 ± 0.630 | 3.985 ± 0.371 ** |
| C15:1 | 3.409 ± 0.477 | 3.265 ± 0.425 | 3.553 ± 0.462 ** | 2.343 ± 0.375 |
| C16:0 | 720.745 ± 114.904 | 842.285 ± 81.702 ** | 684.595 ± 114.603 | 818.974 ± 89.047 ** |
| C16:1T | 6.634 ± 0.663 | 5.943 ± 1.189 | 6.711 ± 1.007 ** | 4.631 ± 0.509 |
| C16:1 | 12.574 ± 1.635 | 12.953 ± 1.425 | 43.014 ± 6.882 * | 45.419 ± 4.959 |
| C17:0 | 6.176 ± 0.679 | 5.563 ± 0.723 | 10.393 ± 1.351 * | 8.286 ± 1.409 |
| C17:1T | 3.979 ± 0.438 | 4.768 ± 0.064 * | 4.767 ± 0.667 | 5.144 ± 0.823 |
| C17:1 | 13.492 ± 1.619 | 13.809 ± 1.243 | 10.885 ± 1.633 | 10.996 ± 1.065 |
| C18:0 | 685.617 ± 75.418 * | 636.980 ± 50.958 | 743.631 ± 118.981 ** | 530.792 ± 58.387 |
| C18:1N12T | 4.529 ± 0.634 | 4.418 ± 0.574 | 5.105 ± 0.664 ** | 3.611 ± 0.506 |
| C18:1N9T | 1.867 ± 0.261 | 1.818 ± 0.031 | 2.156 ± 0.302 * | 1.465 ± 0.249 |
| C18:1N7T | 13.713 ± 1.371 | 13.097 ± 1.572 | 13.746 ± 2.062 ** | 8.928 ± 1.429 |
| C18:1N12 | 103.707 ± 13.482 * | 98.733 ± 17.772 | 202.139 ± 32.342 ** | 150.504 ± 19.566 |
| C18:1N9C | 133.790 ± 14.717 | 159.243 ± 14.332 * | 315.618 ± 48.830 | 375.589 ± 35.815 ** |
| C18:1N7 | 32.803 ± 3.608 | 33.130 ± 3.644 | 46.322 ± 7.885 | 54.113 ± 6.176 ** |
| C18:2N6T | 2.581 ± 0.310 | 2.374 ± 0.475 | 2.704 ± 0.406 * | 1.671 ± 0.284 |
| C19:1N12T | 7.972 ± 0.877 | 7.232 ± 0.795 | 8.779 ± 1.405 ** | 6.573 ± 1.052 |
| C19:1N9T | 4.343 ± 0.608 | 4.018 ± 0.522 | 4.480 ± 0.582 ** | 3.460 ± 0.450 |
| C18:2N6 | 134.054 ± 18.768 | 135.419 ± 14.896 | 302.921 ± 46.609 | 337.498 ± 33.825 * |
| C20:0 | 7.470 ± 0.747 | 6.620 ± 1.324 | 10.259 ± 1.539 * | 7.660 ± 1.072 |
| C18:3N6 | 1.544 ± 0.201 | 2.182 ± 0.393 * | 2.949 ± 0.472 | 3.471 ± 0.590 * |
| C20:1T | 10.219 ± 1.124 * | 7.928 ± 1.031 | 12.548 ± 1.631 * | 8.232 ± 1.317 |
| C20:1 | 6.060 ± 0.667 | 6.743 ± 0.115 | 13.620 ± 1.907 | 17.000 ± 2.210 * |
| C18:3N3 | 5.032 ± 0.604 | 7.294 ± 1.459 * | 22.183 ± 3.327 | 33.338 ± 3.667 ** |
| C21:0 | ND | ND | ND | ND |
| C20:2 | 10.939 ± 1.203 | 12.480 ± 1.123 * | 15.213 ± 1.476 | 17.138 ± 1.256 * |
| C22:0 | 0.972 ± 0.136 | 0.989 ± 0.129 | 1.660 ± 0.346 | 2.397 ± 0.237 * |
| C20:3N6 | 9.218 ± 1.290 * | 6.624 ± 0.113 | 11.758 ± 1.646 ** | 8.422 ± 1.347 |
| C22:1N9T | 5.662 ± 0.566 | 5.308 ± 1.062 | 5.703 ± 0.855 ** | 3.646 ± 0.474 |
| C22:1N9 | 6.024 ± 0.783 | 5.642 ± 1.015 | 6.644 ± 1.063 * | 5.240 ± 0.576 |
| C20:3N3 | 1.688 ± 0.186 | 1.829 ± 0.238 | 1.818 ± 0.236 * | 1.865 ± 0.191 |
| C20:4N6 | 157.671 ± 17.344 * | 135.847 ± 10.460 | 254.602 ± 35.644 ** | 147.414 ± 25.060 |
| C23:0 | ND | ND | 0.480 ± 0.072 ** | ND |
| C22:2 | 2.697 ± 0.297 | 2.600 ± 0.468 | 2.850 ± 0.456 ** | 1.672 ± 0.217 |
| C20:5N3 | 2.707 ± 0.379 | 2.484 ± 0.323 | 2.665 ± 0.346 * | 2.073 ± 0.228 |
| C24:0 | 0.580 ± 0.081 | 0.504 ± 0.086 | 1.435 ± 0.201 ** | 0.628 ± 0.088 |
| C24:1 | 8.811 ± 0.881 | 7.800 ± 1.092 | 9.314 ± 1.397 ** | 6.543 ± 1.112 |
| C22:4 | 31.969 ± 4.156 * | 28.105 ± 3.373 | 49.593 ± 7.935 ** | 34.142 ± 5.463 |
| C22:5N6 | 29.764 ± 3.274 ** | 11.473 ± 1.491 | 14.647 ± 1.904 * | 12.268 ± 1.595 |
| C22:5N3 | 31.388 ± 3.453 | 35.297 ± 3.883 | 29.285 ± 5.500 | 39.901 ± 3.289 ** |
| C22:6N3 | 40.012 ± 4.801 * | 33.988 ± 5.098 | 49.281 ± 7.392 ** | 23.135 ± 3.239 |
| SFA | 1553.587 ± 60.761 | 1520.852 ± 70.393 | 1623.739 ± 113.001 ** | 1265.857 ± 83.291 |
| MUFA | 391.129 ± 41.241 | 402.943 ± 50.201 | 805.201 ± 62.122 ** | 663.502 ± 32.174 |
| PUFA | 450.325 ± 40.226 * | 405.517 ± 40.293 | 787.256 ± 40.110 ** | 606.370 ± 54.231 |
| EFA | 300.883 ± 15.241 * | 283.117 ± 11.321 | 615.359 ± 22.541 ** | 493.392 ± 20.231 |
| TFA | 2406.952 ± 145.035 | 2342.781 ± 131.113 | 3234.067 ± 240.142 ** | 2552.263 ± 152.216 |
Note: Comparison of fatty acid content in the same part of CH and Y males; ** indicates very significant difference (p < 0.01), * indicates significant difference (p < 0.05). SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; EFA, essential fatty acid; TFA, total fatty acids.
Fatty acid content in muscles of females.
| Items | Breast Muscle | Leg Muscle | ||
|---|---|---|---|---|
| Y | CH | Y | CH | |
| C6:0 | 1.149 ± 0.115 * | 0.928 ± 0.074 | 0.986 ± 0.140 * | 0.908 ± 0.119 |
| C8:0 | 1.278 ± 0.141 * | 0.910 ± 0.087 | 0.922 ± 0.092 | 0.914 ± 0.135 |
| C10:0 | 0.675 ± 0.081 | 0.687 ± 0.062 | 0.707 ± 0.078 | 0.715 ± 0.062 |
| C11:0 | ND | ND | ND | ND |
| C12:0 | 1.004 ± 0.160 | 1.290 ± 0.086 * | 1.432 ± 0.136 | 1.651 ± 0.116 * |
| C13:0 | 2.697 ± 0.378 | 2.458 ± 0.270 | 2.412 ± 0.234 | 2.044 ± 0.184 |
| C14:0 | 19.443 ± 2.139 ** | 12.957 ± 1.814 | 27.720 ± 3.049 ** | 15.416 ± 1.449 |
| C14:1T | 8.139 ± 0.977 | 10.346 ± 1.552 ** | 6.260 ± 0.751 | 6.309 ± 0.820 |
| C14:1 | 7.382 ± 1.476 | 8.864 ± 0.709 * | 9.236 ± 1.904 | 11.397 ± 1.368 ** |
| C15:0 | 4.221 ± 0.422 * | 3.560 ± 0.342 | 4.453 ± 0.668 * | 3.559 ± 0.463 |
| C15:1T | 3.339 ± 0.367 | 5.456 ± 0.600 ** | 2.350 ± 0.235 | 2.990 ± 0.350 |
| C15:1 | 3.384 ± 0.406 | 4.669 ± 0.434 ** | 2.493 ± 0.274 | 2.609 ± 0.261 |
| C16:0 | 634.506 ± 108.486 | 857.207 ± 72.293 ** | 697.576 ± 66.270 | 748.156 ± 82.297 * |
| C16:1T | 6.165 ± 0.863 | 6.867 ± 0.961 | 4.970 ± 0.482 | 5.093 ± 0.458 |
| C16:1 | 47.377 ± 5.212 ** | 15.897 ± 2.384 | 110.689 ± 12.176 ** | 28.464 ± 2.676 |
| C17:0 | 7.700 ± 0.924 * | 6.689 ± 0.535 | 9.657 ± 1.159 ** | 6.372 ± 0.828 |
| C17:1T | 3.919 ± 0.784 | 4.278 ± 0.353 * | 4.407 ± 0.436 | 4.810 ± 0.457 * |
| C17:1 | 12.387 ± 1.239 | 13.818 ± 1.300 | 9.114 ± 1.367 | 11.359 ± 1.477 * |
| C18:0 | 641.735 ± 70.591 * | 569.937 ± 53.004 | 558.381 ± 55.438 | 558.121 ± 78.137 |
| C18:1N12T | 4.987 ± 0.598 | 4.165 ± 0.458 | 5.094 ± 0.560 * | 3.814 ± 0.381 |
| C18:1N9T | 2.069 ± 0.269 | 1.745 ± 0.244 | 2.194 ± 0.208 * | 1.580 ± 0.174 |
| C18:1N7T | 12.487 ± 1.748 | 11.700 ± 1.755 | 9.736 ± 0.944 | 10.368 ± 0.933 |
| C18:1N12 | 230.296 ± 25.333 ** | 122.932 ± 9.835 | 172.366 ± 16.760 * | 153.055 ± 16.267 |
| C18:1N9C | 393.985 ± 47.278 ** | 190.700 ± 18.307 | 486.654 ± 58.398 ** | 247.513 ± 32.177 |
| C18:1N7 | 49.226 ± 9.845 ** | 22.913 ± 2.520 | 75.423 ± 7.467 ** | 27.762 ± 3.331 |
| C18:2N6T | 1.353 ± 0.235 | 2.146 ± 0.200 ** | 1.367 ± 0.280 | 1.923 ± 0.250 * |
| C19:1N12T | 7.524 ± 0.828 | 6.727 ± 0.740 | 6.967 ± 0.697 | 7.164 ± 1.003 |
| C19:1N9T | 3.944 ± 0.473 | 3.548 ± 0.497 | 3.531 ± 0.388 | 3.999 ± 0.400 |
| C18:2N6 | 227.792 ± 29.613 ** | 106.984 ± 16.048 | 320.797 ± 30.476 ** | 189.911 ± 20.890 |
| C20:0 | 8.267 ± 1.157 * | 6.836 ± 0.547 | 8.607 ± 0.835 * | 7.047 ± 0.634 |
| C18:3N6 | 2.596 ± 0.286 * | 1.877 ± 0.180 | 3.342 ± 0.368 | 3.183 ± 0.299 |
| C20:1T | 10.850 ± 1.302 | 9.427 ± 1.037 | 11.147 ± 1.338 | 10.135 ± 1.318 |
| C20:1 | 10.870 ± 2.174 ** | 5.691 ± 0.529 | 17.465 ± 1.729 ** | 9.097 ± 1.092 |
| C18:3N3 | 17.258 ± 1.726 ** | 5.903 ± 0.649 | 31.776 ± 4.766 ** | 14.703 ± 1.911 |
| C21:0 | ND | ND | ND | ND |
| C20:2 | 9.809 ± 1.079 * | 7.362 ± 1.031 | 13.007 ± 1.301 ** | 8.615 ± 1.206 |
| C22:0 | 1.311 ± 0.157 | 0.985 ± 0.148 | 1.427 ± 0.157 * | 0.921 ± 0.092 |
| C20:3N6 | 12.975 ± 1.687 ** | 8.355 ± 0.668 | 12.286 ± 1.167 * | 10.603 ± 1.166 |
| C22:1N9T | 4.867 ± 0.681 | 4.224 ± 0.405 | 3.908 ± 0.379 | 3.206 ± 0.379 |
| C22:1N9 | 5.195 ± 0.571 | 4.314 ± 0.475 | 6.151 ± 0.677 | 5.506 ± 0.518 |
| C20:3N3 | 1.368 ± 0.164 * | 1.007 ± 0.094 | 1.353 ± 0.162 * | 1.007 ± 0.131 |
| C20:4N6 | 160.657 ± 32.131 | 137.094 ± 15.080 | 173.462 ± 17.173 * | 128.855 ± 15.463 |
| C23:0 | ND | ND | ND | ND |
| C22:2 | 2.294 ± 0.252 * | 1.863 ± 0.279 | 1.690 ± 0.169 | 1.630 ± 0.256 |
| C20:5N3 | 3.100 ± 0.372 ** | 1.980 ± 0.158 | 1.897 ± 0.209 | 1.755 ± 0.176 |
| C24:0 | 0.678 ± 0.088 | 0.454 ± 0.044 | 0.665 ± 0.063 ** | 0.344 ± 0.038 |
| C24:1 | 8.070 ± 1.130 | 6.706 ± 0.738 | 6.729 ± 0.653 | 6.420 ± 0.668 |
| C22:4 | 35.123 ± 3.864 ** | 20.616 ± 1.917 | 35.356 ± 3.889 ** | 23.653 ± 2.223 |
| C22:5N6 | 13.578 ± 1.6298 * | 7.715 ± 0.849 | 15.091 ± 1.811 * | 13.495 ± 1.754 |
| C22:5N3 | 22.139 ± 4.428 * | 15.839 ± 2.217 | 24.443 ± 2.420 * | 16.273 ± 1.953 |
| C22:6N3 | 44.336 ± 3.434 | 39.308 ± 5.896 | 43.908 ± 6.586 * | 37.290 ± 4.848 |
| SFA | 1530.839 ± 60.423 * | 1275.676 ± 40.341 | 1313.626 ± 60.102 | 1349.857 ± 54.154 |
| MUFA | 829.206 ± 110.560 ** | 450.145 ± 107.216 | 942.727 ± 140.553 ** | 577.909 ± 100.201 |
| PUFA | 535.569 ± 60.403 ** | 350.686 ± 40.201 | 667.269 ± 21.005 ** | 444.482 ± 43.124 |
| EFA | 410.655 ± 40.321 ** | 254.003 ± 20.113 | 531.245 ± 60.100 ** | 338.575 ± 45.211 |
| TFA | 2906.734 ± 120.021 ** | 2084.853 ± 114.121 | 2938.056 ± 159.501 ** | 2381.784 ± 156.421 |
Note: Comparison of fatty acid content in the same part of CH and Y females; ** indicates very significant difference (p < 0.01), * indicates significant difference (p < 0.05). SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; EFA, essential fatty acid; TFA, total fatty acids.
Figure 2Metabolome quality control and quality assurance. (A) BPC diagram of positive and negative ion modes of samples. (B) PCA score chart of positive and negative ion mode of sample quality control.
Figure 3PCA score and PLS−DA. (A) PCA score of positive and negative ion mode in muscle tissue of two kinds of chickens. (B) PLS−DA score chart and replacement test chart of positive and negative ion mode in muscle tissue of two kinds of chickens.
Figure 4Screening and identification of differential metabolites. (A) Statistical results of different metabolites of breast muscle and leg muscle in positive and negative ion mode. (B) Z−score of different metabolites.
Basic information of different metabolites identified in breast muscle.
| Metabolites | Classification |
|---|---|
| Vanillylmandelic acid | Benzene-containing compounds |
| Gallic acid | Benzene-containing compounds |
| Gentisic acid | Benzene-containing compounds |
| Adenosine | Nucleoside and nucleotide acid analogues |
| Nicotinamide ribotide | Nucleoside and nucleotide acid analogues |
| Lithocholyltaurine | Lipids and lipid molecules |
| 2-Oxo-4-methylthiobutanoic acid | Lipids and lipid molecules |
| Dethiobiotin | Lipids and lipid molecules |
| Bovinic acid | Lipids and lipid molecules |
| γ-L-Glutamyl-L-cysteine | Organic acids and their derivatives |
| L-Lysine | Organic acids and their derivatives |
| Homo-L-arginine | Organic acids and their derivatives |
| 12-Hydroxydodecanoic acid | Organic acids and their derivatives |
| Asymmetric dimethylarginine | Organic acids and their derivatives |
| 1-Aminocyclopropanecarboxylic acid | Organic acids and their derivatives |
| 2-Ketohexanoic acid | Organic acids and their derivatives |
| 1-Methylhistidine | Organic acids and their derivatives |
| N6-Acetyl-L-lysine | Organic acids and their derivatives |
| Ergothioneine | Organic acids and their derivatives |
| L-Malic acid | Organic acids and their derivatives |
| L-Glutamine | Organic acids and their derivatives |
| L-Threonine | Organic acids and their derivatives |
| (R)-3-Hydroxybutyric acid | Organic acids and their derivatives |
| L-Valine | Organic acids and their derivatives |
| 1-Pyrroline-4-hydroxy-2-carboxylate | Organic heterocyclic compounds |
| N-Acetylserotonin | Organic heterocyclic compounds |
| Indolin-2-one | Organic heterocyclic compounds |
| Glutethimide | Organic heterocyclic compounds |
| Theophylline | Organic heterocyclic compounds |
| D-1-Piperideine-2-carboxylic acid | Organic heterocyclic compounds |
| 2-Furoate | Organic heterocyclic compounds |
| 4-(2-Aminophenyl)-2,4-dioxobutanoic acid | Organic oxygenates |
| Shikimic acid | Organic oxygenates |
| β-D-Fructose | Organic oxygenates |
| Biotinyl-5-AMP | Hydrocarbon derivatives |
| 8-Amino-7-oxononanoate | N |
| 3-Methyl-L-tyrosine | N |
| 1-Arachidonoylglycerol | N |
| Ophthalmate | N |
| 5-Hydroxymethylfurfuryl alcohol | N |
| 2,4-Dinitrophenol | N |
| 3-Methyloxindole | N |
Basic information of different metabolites identified in leg muscle.
| Metabolites | Classification |
|---|---|
| 3-Methylindole | Benzene-containing compounds |
| Creatinine | Benzene-containing compounds |
| Hexadecanedioate | Benzene-containing compounds |
| Protoporphyrinogen IX | Nucleoside and nucleotide acid analogues |
| N6-Acetyl-L-lysine | Nucleoside and nucleotide acid analogues |
| Prostaglandin F2a | Nucleoside and nucleotide acid analogues |
| Indolin-2-one | Lipids and lipid molecules |
| AMP | Lipids and lipid molecules |
| Rosmarinic acid | Lipids and lipid molecules |
| 5-Methylthioadenosine | Lipids and lipid molecules |
| Apigenin | Lipids and lipid molecules |
| Ophthalmate | Lipids and lipid molecules |
| 5-Hydroxyindoleacetic acid | Lipids and lipid molecules |
| L-Proline | Organic acids and their derivatives |
| Glucose 6-phosphate | Organic acids and their derivatives |
| L-Arginine | Organic acids and their derivatives |
| 3-Carbamoyl-2-phenylpropionaldehyde | Organic acids and their derivatives |
| L-Methionine | Organic acids and their derivatives |
| O-Acetylcarnitine | Organic acids and their derivatives |
| 4-(2-Aminophenyl)-2,4-dioxobutanoic acid | Organic acids and their derivatives |
| Creatine | Organic acids and their derivatives |
| 3-Dehydroecdysone | Organic acids and their derivatives |
| 2,4-Dinitrophenol | Organic acids and their derivatives |
| Phenylethylamine | Organic acids and their derivatives |
| 2-Methylbutanal | Organic acids and their derivatives |
| Taurocholic acid | Organic acids and their derivatives |
| Geranyl diphosphate | Organic acids and their derivatives |
| Xanthine | Organic acids and their derivatives |
| Anabasine | Organic heterocyclic compounds |
| Isonicotinic acid | Organic heterocyclic compounds |
| Hypoxanthine | Organic heterocyclic compounds |
| Aminocaproic acid | Organic heterocyclic compounds |
| L-Lactic acid | Organic heterocyclic compounds |
| Norselegiline | Organic heterocyclic compounds |
| Antibiotic JI-20A | Organic heterocyclic compounds |
| Lithocholyltaurine | Organic heterocyclic compounds |
| dGMP | Organic oxygenates |
| (R)-3-Hydroxybutyric acid | Organic oxygenates |
| L-Glutamic acid | Organic oxygenates |
| β-D-Fructose | Organic oxygenates |
| 3-Methyloxindole | Phenylpropane and polyketone |
| 1-palmitoylglycerophosphocholine | Phenylpropane and polyketone |
| 5,7-Dihydroxyflavone | Phenylpropane and polyketone |
| Taurine | Alkaloid and their derivatives |
| 5,6-Dihydro-5-fluorouracil | N |
| 2-Ketobutyric acid | N |
| (R)-5,6-Dihydrothymine | N |
| γ-L-Glutamyl-L-cysteine | N |
| N-Acetylhistamine | N |
| β-Glycerophosphoric acid | N |
| Hippuric acid | N |
| S-Lactoylglutathione | N |
| Ergothioneine | N |
| L-Threonine | N |
| (S)-4-Hydroxymandelate | N |
Figure 5Thermogram of different metabolites in muscle tissue.
Figure 6KEGG pathway enrichment. (A) Metabolic pathway influencing factors in breast muscle tissue. (B) Metabolic pathway influencing factors in leg muscle tissue. (C) Relative expression of gene.
Pathways of KEGG enrichment of different metabolites in breast muscle.
| Metabolic Pathway | Total Metabolites | Different Metabolites |
|---|---|---|
| Biotin metabolism | 28 | 4 |
| Aminoacyl-tRNA biosynthesis | 52 | 4 |
| Lysine degradation | 50 | 3 |
| ABC transporters | 138 | 5 |
| Valine, leucine and isoleucine biosynthesis | 23 | 2 |
| Cysteine and methionine metabolism | 63 | 3 |
Pathways of KEGG enrichment of different metabolites in leg muscle.
| Metabolic Pathway | Total Metabolites | Different Metabolites |
|---|---|---|
| mTOR signaling pathway | 4 | 2 |
| Aminoacyl-tRNA biosynthesis | 52 | 5 |
| 5 | 2 | |
| Taurine and hypotaurine metabolism | 22 | 3 |
| Arginine and proline metabolism | 78 | 5 |
| Cysteine and methionine metabolism | 63 | 4 |
| Histidine metabolism | 47 | 3 |
| Glycine, serine and threonine metabolism | 50 | 3 |
Basic information of related pathways.
| Fat Deposition Pathways | Classification | Metabolites |
|---|---|---|
| β-Alanine metabolism | Metabolism of other amino acids | L-Aspartic acid; Anserine; Uracil; β-Alanine; |
| Histidine metabolism | Amino acid metabolism | Anserine; 3-Methylhistidine; Carnosine; |
| mTOR signaling pathway | Signal transduction | AMP; L-Arginine |
| Sphingolipid metabolism | Lipid metabolism | Sphingosine 1-phosphate; |
| Endocrine system | 9-cis-Retinoic acid; 9(S)-HODE; Leukotriene B4 | |
| Fatty acid degradation | Lipid metabolism | Glutaryl-CoA; Long-chain fatty acid; Glutarate; |
| Fatty acid biosynthesis | Lipid metabolism | Palmitoleic acid; Hexadecanoate |
| Steroid biosynthesis | Lipid metabolism | Ergocalciferol; Ergosterol; Episterol; |
| Linoleic acid metabolism | Lipid metabolism | (13S)-Hydroxyoctadecadienoic acid; |
| Citrate cycle (TCA cycle) | Carbohydrate metabolism | L-Malate; 2-Oxoglutarate |
Screening gene information.
| Gene | Gene Name |
|---|---|
|
| peroxisome proliferator-activated receptor α |
|
| peroxisome proliferator-activated receptor γ |
|
| acetyl-CoA carboxylase α |
|
| fatty acid binding protein 3 |
|
| acyl-CoA synthetase long-chain family member 5 |
|
| fatty acid synthase |
|
| uncoupling protein 3 |
|
| sterol-C5-desaturase |
|
| acyl-CoA oxidase 1 |